Liver Dangers of Herbal Products: A Case Report of Ashwagandha-Induced Liver Injury
Authors:
- Marta LubarskaMLMarta Lubarska
- Przemysław HałasińskiPHPrzemysław Hałasiński
- Szymon HryhorowiczSHSzymon Hryhorowicz
- Dagmara Santabye MahadeaDMDagmara Santabye Mahadea
- Liliana Łykowska-SzuberLŁLiliana Łykowska-Szuber
- Piotr EderPiotr Eder
- Agnieszka DobrowolskaADAgnieszka Dobrowolska
- Iwona Krela-KaźmierczakIKIwona Krela-Kaźmierczak
Open Access
- 22 February 2023
- journal article
- case report
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 20 (5) , 3921
Abstract
In recent years, cases of liver damage caused by ashwagandha herbal supplements have been reported from different parts of the world (Japan, Iceland, India, and the USA). Here, we describe the clinical phenotype of suspected ashwagandha-induced liver injury and the potential causative mechanism. The patient was admitted to the hospital because of jaundice. In the interview, it was reported that he had been taking ashwagandha for a year. Laboratory results showed an increase in total bilirubin, alanine transaminase (ALT), aspartate transaminase (AST), (gamma-glutamyl transpherase (GGT), alkaline phosphatase (ALP), total cholesterol, triglycerides, and ferritin. Based on clinical symptoms and additional tests, the patient was diagnosed with acute hepatitis and referred to a facility with a higher reference rate to exclude drug-induced liver injury. An R-value was assessed, indicative of hepatocellular injury. The result of the 24 h urine collection exceeded the upper limit of normal for copper excretion in urine twice. The clinical condition improved after intensive pharmacological treatment and four plasmapheresis treatments. This case is another showing the hepatotoxic potential of ashwagandha to cause cholestatic liver damage mixed with severe jaundice. In view of several documented cases of liver damage caused by ashwagandha and the unknown metabolic molecular mechanisms of substances contained in it, attention should be paid to patients reporting the use of these products in the past and presenting symptoms of liver damage.Keywords
This publication has 40 references indexed in Scilit:
- Differential Activities of the Two Closely Related Withanolides, Withaferin A and Withanone: Bioinformatics and Experimental EvidencesPLOS ONE, 2012
- Selective Killing of Cancer Cells by Ashwagandha Leaf Extract and Its Component Withanone Involves ROS SignalingPLOS ONE, 2010
- Steroidal Lactones from Withania somnifera, an Ancient Plant for Novel MedicineMolecules, 2009
- In Vivo Effects of Ashwagandha ( Withania somnifera ) Extract on the Activation of LymphocytesThe Journal of Alternative and Complementary Medicine, 2009
- Selective Killing of Cancer Cells by Leaf Extract of Ashwagandha: Identification of a Tumor-Inhibitory Factor and the First Molecular Insights to Its EffectClinical Cancer Research, 2007
- Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechinsFree Radical Biology and Medicine, 2006
- Usnic acid-induced necrosis of cultured mouse hepatocytes: inhibition of mitochondrial function and oxidative stressBiochemical Pharmacology, 2004
- In Vitro Toxicity of Kava Alkaloid, Pipermethystine, in HepG2 Cells Compared to KavalactonesToxicological Sciences, 2004
- DRUG-INDUCED LIVER DISEASEClinics in Liver Disease, 2000
- New Withanolides from Withania sp.Journal of Natural Products, 1993